| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | PFIZER INC | 626,438 | 22,057,000 | 19.10% | ||
| 2 | GLAXOSMITHKLINE PLC | 470,000 | 20,370,000 | 17.64% | ||
| 3 | SHIRE PLC | 74,000 | 13,622,000 | 11.80% | ||
| 4 | SEATTLE GENETICS INC | 151,500 | 6,122,000 | 5.30% | ||
| 5 | MYLAN N V | 140,000 | 6,054,000 | 5.24% | ||
| 6 | LANNET INC COM NEW | 230,000 | 5,472,000 | 4.74% | ||
| 7 | AMGEN INC | 30,000 | 4,565,000 | 3.95% | ||
| 8 | CYNAPSUS THERAPEUTICS INC | 244,310 | 4,092,000 | 3.54% | ||
| 9 | ACCELERON PHARMA | 99,000 | 3,364,000 | 2.91% | ||
| 10 | Aquinox Pharmaceuticals Inc | 498,300 | 3,299,000 | 2.86% | ||
| 11 | ADAMAS PHARMACEUTICALS INC | 178,240 | 2,699,000 | 2.34% | ||
| 12 | FIBROGEN INC COM | 154,000 | 2,527,000 | 2.19% | ||
| 13 | CONCERT PHARMACEUTICALS INC COM | 183,000 | 2,055,000 | 1.78% | ||
| 14 | AERIE PHARMACEUTICALS INC | 110,280 | 1,941,000 | 1.68% | ||
| 15 | ARRAY BIOPHARMA INC COM | 521,000 | 1,855,000 | 1.61% | ||
| 16 | INSMED INC COM PAR .01 | 168,700 | 1,663,000 | 1.44% | ||
| 17 | EDGE THERAPEUTICS INC | 135,836 | 1,373,000 | 1.19% | ||
| 18 | IGNYTA INC COM | 235,000 | 1,274,000 | 1.10% | ||
| 19 | MINERVA NEUROSCIENCES INC COM | 107,000 | 1,092,000 | 0.95% | ||
| 20 | ADVAXIS INC COM NEW | 125,000 | 1,011,000 | 0.88% | ||
| 21 | ALDER BIOPHARMACEUTICALS INC | 39,000 | 974,000 | 0.84% | ||
| 22 | TREVENA INC | 150,000 | 945,000 | 0.82% | ||
| 23 | TOBIRA THERAPEUTICS INC | 75,000 | 942,000 | 0.82% | ||
| 24 | Foamix Pharmaceuticals Ltd. | 145,250 | 922,000 | 0.80% | ||
| 25 | IMMUNE DESIGN CORP COM | 85,138 | 695,000 | 0.60% | ||
| 26 | UNIQURE NV | 93,400 | 688,000 | 0.60% | ||
| 27 | SCYNEXIS INC | 275,000 | 597,000 | 0.52% | ||
| 28 | VistaGen Therapeutics Inc | 138,132 | 539,000 | 0.47% | ||
| 29 | AVEO PHARMACEUTICALS INC | 518,134 | 498,000 | 0.43% | ||
| 30 | VERASTEM INC COM | 336,000 | 437,000 | 0.38% | ||
| 31 | IMMUNOGEN INCORPORATED | 140,500 | 433,000 | 0.37% | ||
| 32 | PROGENICS PHARMACEUTICALS IN | 96,000 | 405,000 | 0.35% | ||
| 33 | ZYNERBA PHARMACEUTICALS INC | 57,100 | 391,000 | 0.34% | ||
| 34 | EIGER BIOPHARMACEUTICALS INC | 14,000 | 277,000 | 0.24% | ||
| 35 | ABEONA THERAPEUTICS INC | 100,000 | 236,000 | 0.20% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001646343-16-000008, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
